Baidu
map

CEBP:身高较高的绝经后女性,患癌风险明显增加

2013-07-26 林小春 MedSci原创

人们普遍认为,肥胖是癌症的重要风险因素。然而美国一项最新研究声称,个头高的女性,其患癌风险也高。美国耶希瓦大学研究人员25日在《癌症流行病学、生物标志和预防》杂志上报告说,他们对约14.5万名50岁至79岁的女性进行了12年的跟踪研究,其中近2.1万人在研究期间被确诊罹患一种或多种癌症。 研究人员发现,女性身高每增加10厘米,罹患黑素瘤、乳腺癌、卵巢癌、子宫内膜癌和结肠癌等癌症的风险增加13

人们普遍认为,肥胖是癌症的重要风险因素。然而美国最新一项前瞻性队列研究表明,个头高的女性,其患癌风险也高。而且很少研究关注这一点。

美国耶希瓦大学研究人员25日在《癌症流行病学、生物标志和预防》杂志上报告说,他们对约144,701名50岁至79岁的女性进行了12年的跟踪研究,其中近 20,928人在研究期间被确诊罹患一种或多种癌症。

研究人员发现,绝经期后的女性升高与肿瘤的风险为HR = 1.13(95% CI, 1.11–1.16),女性身高每增加10厘米,罹患黑素瘤、乳腺癌、卵巢癌、子宫内膜癌和结肠癌等癌症的风险增加13%至17%;而罹患肾癌、直肠癌和甲状腺癌等癌症风险增加23%至29%。

研究人员表示,他们共研究了19种癌症,研究中排除了年龄、体重、教育、抽烟、饮酒和激素疗法等影响因素。

针对这一结果,研究第一作者、耶希瓦大学爱因斯坦医学院的杰弗里·卡巴特表示:“我们很惊讶。我们的研究发现,更多的癌症是与身高而不是肥胖程度相关。这一研究的意义在于,影响身高的激素或其他生长因素可能也是癌症的风险因素。”

原始出处:

Geoffrey C. Kabat,Matthew L. Anderson,Moonseong Heo,et al.Adult Stature and Risk of Cancer at Different Anatomic Sites in a Cohort of Postmenopausal Women. Cancer Epidemiol Biomarkers Prev.Published OnlineFirst July 25, 2013; doi:10.1158/1055-9965.EPI-13-0305

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2061389, encodeId=316c206138909, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Tue Aug 13 23:07:00 CST 2013, time=2013-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6000, encodeId=3c54600079, content=有的惊讶,还好我个子不高。, beContent=null, objectType=article, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bafb47087, createdName=kljjma, createdTime=Wed Aug 07 10:57:00 CST 2013, time=2013-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1256987, encodeId=9d74125698efb, content=<a href='/topic/show?id=cdfce8879b1' target=_blank style='color:#2F92EE;'>#绝经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78879, encryptionId=cdfce8879b1, topicName=绝经)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=yeye5224612, createdTime=Sun Jul 28 06:07:00 CST 2013, time=2013-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1413415, encodeId=81a41413415df, content=<a href='/topic/show?id=3f225299942' target=_blank style='color:#2F92EE;'>#患癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52999, encryptionId=3f225299942, topicName=患癌风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b2c2959841, createdName=zzc2212, createdTime=Sun Jul 28 06:07:00 CST 2013, time=2013-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1526600, encodeId=f00d152660098, content=<a href='/topic/show?id=2fe6e88863a' target=_blank style='color:#2F92EE;'>#绝经后女性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78886, encryptionId=2fe6e88863a, topicName=绝经后女性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b55511745984, createdName=chenhongpeng, createdTime=Sun Jul 28 06:07:00 CST 2013, time=2013-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601322, encodeId=5fa81601322b8, content=<a href='/topic/show?id=5baa5299111' target=_blank style='color:#2F92EE;'>#患癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52991, encryptionId=5baa5299111, topicName=患癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=888f18872716, createdName=lq0307, createdTime=Sun Jul 28 06:07:00 CST 2013, time=2013-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1631477, encodeId=362c16314e795, content=<a href='/topic/show?id=6395e888343' target=_blank style='color:#2F92EE;'>#绝经后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78883, encryptionId=6395e888343, topicName=绝经后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32b921798518, createdName=zxxiang, createdTime=Sun Jul 28 06:07:00 CST 2013, time=2013-07-28, status=1, ipAttribution=)]
    2013-08-13 sjq027
  2. [GetPortalCommentsPageByObjectIdResponse(id=2061389, encodeId=316c206138909, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Tue Aug 13 23:07:00 CST 2013, time=2013-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6000, encodeId=3c54600079, content=有的惊讶,还好我个子不高。, beContent=null, objectType=article, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bafb47087, createdName=kljjma, createdTime=Wed Aug 07 10:57:00 CST 2013, time=2013-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1256987, encodeId=9d74125698efb, content=<a href='/topic/show?id=cdfce8879b1' target=_blank style='color:#2F92EE;'>#绝经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78879, encryptionId=cdfce8879b1, topicName=绝经)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=yeye5224612, createdTime=Sun Jul 28 06:07:00 CST 2013, time=2013-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1413415, encodeId=81a41413415df, content=<a href='/topic/show?id=3f225299942' target=_blank style='color:#2F92EE;'>#患癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52999, encryptionId=3f225299942, topicName=患癌风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b2c2959841, createdName=zzc2212, createdTime=Sun Jul 28 06:07:00 CST 2013, time=2013-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1526600, encodeId=f00d152660098, content=<a href='/topic/show?id=2fe6e88863a' target=_blank style='color:#2F92EE;'>#绝经后女性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78886, encryptionId=2fe6e88863a, topicName=绝经后女性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b55511745984, createdName=chenhongpeng, createdTime=Sun Jul 28 06:07:00 CST 2013, time=2013-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601322, encodeId=5fa81601322b8, content=<a href='/topic/show?id=5baa5299111' target=_blank style='color:#2F92EE;'>#患癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52991, encryptionId=5baa5299111, topicName=患癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=888f18872716, createdName=lq0307, createdTime=Sun Jul 28 06:07:00 CST 2013, time=2013-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1631477, encodeId=362c16314e795, content=<a href='/topic/show?id=6395e888343' target=_blank style='color:#2F92EE;'>#绝经后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78883, encryptionId=6395e888343, topicName=绝经后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32b921798518, createdName=zxxiang, createdTime=Sun Jul 28 06:07:00 CST 2013, time=2013-07-28, status=1, ipAttribution=)]
    2013-08-07 kljjma

    有的惊讶,还好我个子不高。

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2061389, encodeId=316c206138909, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Tue Aug 13 23:07:00 CST 2013, time=2013-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6000, encodeId=3c54600079, content=有的惊讶,还好我个子不高。, beContent=null, objectType=article, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bafb47087, createdName=kljjma, createdTime=Wed Aug 07 10:57:00 CST 2013, time=2013-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1256987, encodeId=9d74125698efb, content=<a href='/topic/show?id=cdfce8879b1' target=_blank style='color:#2F92EE;'>#绝经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78879, encryptionId=cdfce8879b1, topicName=绝经)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=yeye5224612, createdTime=Sun Jul 28 06:07:00 CST 2013, time=2013-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1413415, encodeId=81a41413415df, content=<a href='/topic/show?id=3f225299942' target=_blank style='color:#2F92EE;'>#患癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52999, encryptionId=3f225299942, topicName=患癌风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b2c2959841, createdName=zzc2212, createdTime=Sun Jul 28 06:07:00 CST 2013, time=2013-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1526600, encodeId=f00d152660098, content=<a href='/topic/show?id=2fe6e88863a' target=_blank style='color:#2F92EE;'>#绝经后女性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78886, encryptionId=2fe6e88863a, topicName=绝经后女性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b55511745984, createdName=chenhongpeng, createdTime=Sun Jul 28 06:07:00 CST 2013, time=2013-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601322, encodeId=5fa81601322b8, content=<a href='/topic/show?id=5baa5299111' target=_blank style='color:#2F92EE;'>#患癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52991, encryptionId=5baa5299111, topicName=患癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=888f18872716, createdName=lq0307, createdTime=Sun Jul 28 06:07:00 CST 2013, time=2013-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1631477, encodeId=362c16314e795, content=<a href='/topic/show?id=6395e888343' target=_blank style='color:#2F92EE;'>#绝经后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78883, encryptionId=6395e888343, topicName=绝经后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32b921798518, createdName=zxxiang, createdTime=Sun Jul 28 06:07:00 CST 2013, time=2013-07-28, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2061389, encodeId=316c206138909, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Tue Aug 13 23:07:00 CST 2013, time=2013-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6000, encodeId=3c54600079, content=有的惊讶,还好我个子不高。, beContent=null, objectType=article, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bafb47087, createdName=kljjma, createdTime=Wed Aug 07 10:57:00 CST 2013, time=2013-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1256987, encodeId=9d74125698efb, content=<a href='/topic/show?id=cdfce8879b1' target=_blank style='color:#2F92EE;'>#绝经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78879, encryptionId=cdfce8879b1, topicName=绝经)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=yeye5224612, createdTime=Sun Jul 28 06:07:00 CST 2013, time=2013-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1413415, encodeId=81a41413415df, content=<a href='/topic/show?id=3f225299942' target=_blank style='color:#2F92EE;'>#患癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52999, encryptionId=3f225299942, topicName=患癌风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b2c2959841, createdName=zzc2212, createdTime=Sun Jul 28 06:07:00 CST 2013, time=2013-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1526600, encodeId=f00d152660098, content=<a href='/topic/show?id=2fe6e88863a' target=_blank style='color:#2F92EE;'>#绝经后女性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78886, encryptionId=2fe6e88863a, topicName=绝经后女性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b55511745984, createdName=chenhongpeng, createdTime=Sun Jul 28 06:07:00 CST 2013, time=2013-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601322, encodeId=5fa81601322b8, content=<a href='/topic/show?id=5baa5299111' target=_blank style='color:#2F92EE;'>#患癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52991, encryptionId=5baa5299111, topicName=患癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=888f18872716, createdName=lq0307, createdTime=Sun Jul 28 06:07:00 CST 2013, time=2013-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1631477, encodeId=362c16314e795, content=<a href='/topic/show?id=6395e888343' target=_blank style='color:#2F92EE;'>#绝经后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78883, encryptionId=6395e888343, topicName=绝经后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32b921798518, createdName=zxxiang, createdTime=Sun Jul 28 06:07:00 CST 2013, time=2013-07-28, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2061389, encodeId=316c206138909, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Tue Aug 13 23:07:00 CST 2013, time=2013-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6000, encodeId=3c54600079, content=有的惊讶,还好我个子不高。, beContent=null, objectType=article, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bafb47087, createdName=kljjma, createdTime=Wed Aug 07 10:57:00 CST 2013, time=2013-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1256987, encodeId=9d74125698efb, content=<a href='/topic/show?id=cdfce8879b1' target=_blank style='color:#2F92EE;'>#绝经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78879, encryptionId=cdfce8879b1, topicName=绝经)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=yeye5224612, createdTime=Sun Jul 28 06:07:00 CST 2013, time=2013-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1413415, encodeId=81a41413415df, content=<a href='/topic/show?id=3f225299942' target=_blank style='color:#2F92EE;'>#患癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52999, encryptionId=3f225299942, topicName=患癌风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b2c2959841, createdName=zzc2212, createdTime=Sun Jul 28 06:07:00 CST 2013, time=2013-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1526600, encodeId=f00d152660098, content=<a href='/topic/show?id=2fe6e88863a' target=_blank style='color:#2F92EE;'>#绝经后女性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78886, encryptionId=2fe6e88863a, topicName=绝经后女性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b55511745984, createdName=chenhongpeng, createdTime=Sun Jul 28 06:07:00 CST 2013, time=2013-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601322, encodeId=5fa81601322b8, content=<a href='/topic/show?id=5baa5299111' target=_blank style='color:#2F92EE;'>#患癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52991, encryptionId=5baa5299111, topicName=患癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=888f18872716, createdName=lq0307, createdTime=Sun Jul 28 06:07:00 CST 2013, time=2013-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1631477, encodeId=362c16314e795, content=<a href='/topic/show?id=6395e888343' target=_blank style='color:#2F92EE;'>#绝经后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78883, encryptionId=6395e888343, topicName=绝经后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32b921798518, createdName=zxxiang, createdTime=Sun Jul 28 06:07:00 CST 2013, time=2013-07-28, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=2061389, encodeId=316c206138909, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Tue Aug 13 23:07:00 CST 2013, time=2013-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6000, encodeId=3c54600079, content=有的惊讶,还好我个子不高。, beContent=null, objectType=article, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bafb47087, createdName=kljjma, createdTime=Wed Aug 07 10:57:00 CST 2013, time=2013-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1256987, encodeId=9d74125698efb, content=<a href='/topic/show?id=cdfce8879b1' target=_blank style='color:#2F92EE;'>#绝经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78879, encryptionId=cdfce8879b1, topicName=绝经)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=yeye5224612, createdTime=Sun Jul 28 06:07:00 CST 2013, time=2013-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1413415, encodeId=81a41413415df, content=<a href='/topic/show?id=3f225299942' target=_blank style='color:#2F92EE;'>#患癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52999, encryptionId=3f225299942, topicName=患癌风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b2c2959841, createdName=zzc2212, createdTime=Sun Jul 28 06:07:00 CST 2013, time=2013-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1526600, encodeId=f00d152660098, content=<a href='/topic/show?id=2fe6e88863a' target=_blank style='color:#2F92EE;'>#绝经后女性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78886, encryptionId=2fe6e88863a, topicName=绝经后女性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b55511745984, createdName=chenhongpeng, createdTime=Sun Jul 28 06:07:00 CST 2013, time=2013-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601322, encodeId=5fa81601322b8, content=<a href='/topic/show?id=5baa5299111' target=_blank style='color:#2F92EE;'>#患癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52991, encryptionId=5baa5299111, topicName=患癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=888f18872716, createdName=lq0307, createdTime=Sun Jul 28 06:07:00 CST 2013, time=2013-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1631477, encodeId=362c16314e795, content=<a href='/topic/show?id=6395e888343' target=_blank style='color:#2F92EE;'>#绝经后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78883, encryptionId=6395e888343, topicName=绝经后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32b921798518, createdName=zxxiang, createdTime=Sun Jul 28 06:07:00 CST 2013, time=2013-07-28, status=1, ipAttribution=)]
    2013-07-28 lq0307
  7. [GetPortalCommentsPageByObjectIdResponse(id=2061389, encodeId=316c206138909, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Tue Aug 13 23:07:00 CST 2013, time=2013-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=6000, encodeId=3c54600079, content=有的惊讶,还好我个子不高。, beContent=null, objectType=article, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bafb47087, createdName=kljjma, createdTime=Wed Aug 07 10:57:00 CST 2013, time=2013-08-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1256987, encodeId=9d74125698efb, content=<a href='/topic/show?id=cdfce8879b1' target=_blank style='color:#2F92EE;'>#绝经#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78879, encryptionId=cdfce8879b1, topicName=绝经)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=yeye5224612, createdTime=Sun Jul 28 06:07:00 CST 2013, time=2013-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1413415, encodeId=81a41413415df, content=<a href='/topic/show?id=3f225299942' target=_blank style='color:#2F92EE;'>#患癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52999, encryptionId=3f225299942, topicName=患癌风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8b2c2959841, createdName=zzc2212, createdTime=Sun Jul 28 06:07:00 CST 2013, time=2013-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1526600, encodeId=f00d152660098, content=<a href='/topic/show?id=2fe6e88863a' target=_blank style='color:#2F92EE;'>#绝经后女性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=77, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78886, encryptionId=2fe6e88863a, topicName=绝经后女性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b55511745984, createdName=chenhongpeng, createdTime=Sun Jul 28 06:07:00 CST 2013, time=2013-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1601322, encodeId=5fa81601322b8, content=<a href='/topic/show?id=5baa5299111' target=_blank style='color:#2F92EE;'>#患癌#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52991, encryptionId=5baa5299111, topicName=患癌)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=888f18872716, createdName=lq0307, createdTime=Sun Jul 28 06:07:00 CST 2013, time=2013-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1631477, encodeId=362c16314e795, content=<a href='/topic/show?id=6395e888343' target=_blank style='color:#2F92EE;'>#绝经后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78883, encryptionId=6395e888343, topicName=绝经后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32b921798518, createdName=zxxiang, createdTime=Sun Jul 28 06:07:00 CST 2013, time=2013-07-28, status=1, ipAttribution=)]
    2013-07-28 zxxiang

相关资讯

Nat Immuno:干扰素β/IFNAR1激活免疫机制

日前,来自澳洲莫纳什大学的科学家们通过研究获得了关于免疫反应早期阶段的新见解,这为从多发性硬化症到癌症等许多疾病开发治疗提供了一些新的途径。这项刊登在《自然免疫学》(Nature Immunology)杂志上的研究首次确定了,β干扰素(interferon beta, IFNβ)蛋白结合细胞并激活免疫反应的机制特征。 当身体检测到病毒或细菌感染时,干扰素β就会产生。对于身体的抵御能力来说,干

Immunocore公司:用自身T细胞杀死癌细胞

癌症一直是人类的梦魇,攻克癌症也成为无数科学家和医学人士殚精竭虑、孜孜以求的“圣杯”。各种抗癌方法层出不穷,但大多都在癌症强大的防御面前溃不成军。不过,这种情况有望获得改善。 现在,英国科学家另辟蹊径,提出了一种抗癌新方法:使用人体血液内的 T 细胞来杀死恶性肿瘤。这一技术目前还处于临床试验的第一阶段,结果如何?可能需要 5 年到 10 年时间,答案才能揭晓。 另辟蹊径: T 细胞杀死癌细胞

eLife: 生物信息学显示两药联合靶向抗癌可能提高疗效

哈佛大学的一项新发现正在造就现代医学史上的新的圣杯:彻底治愈癌症。 近日,一项在线刊登在《eLife》杂志上的研究详细描述了这项新的医学里程碑。数学生物学家、进化动力学项目主任 Martin Nowak 和数学博士后研究员 Ivana Bozic 作为该里程碑的塑造者指出,应用两种抗癌药物联合靶向治疗,在某些情况下可有效地治愈几乎所有的癌症,这种治疗方法是一种基于中断癌症的生长和扩散能力的治

Nat Rev Immunol:联合免疫疗法:癌症治疗的新策略

肿瘤能够通过开发保护健康宿主细胞的调控网络来逃避免疫系统,从而避免免疫介导的供给。瞄准此类路径为治疗癌症病人带来了希望,然而越来越明显的是,一种联合疗法很可能需要临床疗效。最近发表在《科学》和《临床调查期刊》上的两项研究如今描述了癌症治疗联合免疫疗法的大有希望的新策略。 CD47被宿主细胞所表达,其功能相当于向巨噬细胞发出一个“别吃我”的信号,而巨噬细胞能够通过信号调节蛋白质-α (SIRPα;

Nature:裸鼹鼠抗癌能力揭秘

裸鼹鼠引人瞩目之处在于它们寿命极长,同时对癌症几乎有完全的抵抗力。现在,一个新颖的糖胺多糖变体被发现是它们抗癌能力的一个关键贡献因素。该变体使这种动物具有在地下生活所需的结实而柔和的皮肤。透明质酸是细胞外基质的一个普遍成分。Xiao Tian等人发现,裸鼹鼠成纤维细胞的培养介质会因一种粘稠物质的积累而变得有粘性,同时他们还识别出该物质是一种“高分子量透明质酸” (HMM-HA) ,比小鼠和人类的相

Eric Bennett教授:泛素-蛋白酶体系统可能是ALS和PD、癌症治愈的希望

据加州大学生物科学部刊登的学术文章称,该校细胞与发育生物学部教授Eric Bennett带领的Bennett 实验室正在用综合的生化学方法和细胞生物学方法研究泛素-蛋白酶体系统(UPS)。UPS被生物学界喻为细胞的废物管理系统,是细胞的质量控制系统,人类一旦了解并参与UPS的作用机理,很多疑难杂症,诸如肌萎缩侧索硬化症(ALS)、帕金森综合症(PD)、癌症都将被治愈。 英文阅读: Assist

Baidu
map
Baidu
map
Baidu
map